Hosted on MSN2d
AI-powered blood test revolutionizes early cancer detection
Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...
technologynetworks3d
Advances in Biomarker Discovery: From Disease Detection to Cure
Biomarkers – measurable biological indicators found in blood, bodily fluids or tissues – reflect changes from normal ...
Medindia12d
Cell-Free DNA in Urine: A New Biomarker for UTUC Detection
Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less ...
BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction
BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...
Too Old to Operate9d
Which Factors Influence Biopsy Approach & Therapy Sequence in Metastatic ER+ Breast Cancer?
Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...
Targeted Oncology3d
Liquid Biopsy Techniques Test Lung Cancer MRD Level
Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...
Guardant Health announces collaboration with Boehringer Ingelheim
Guardant Health (GH) announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the ...
Taiwan News3d
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer. The company is announcing ...
Refractory Follicular Lymphoma Diagnostics Market Trends and Forecasts to 2029 - The Rise of Liquid Biopsy
Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...
Stockhouse11d
BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction
BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver ... will share data highlighting how plasma metabolomics can be applied to lobular breast cancer biomarker ...